Use of Genomic Testing in Breast Cancer Has Greater Impact on Treatment, Costs

Use of Genomic Testing in Breast Cancer Has Greater Impact on Treatment, Costs

Receipt of the 21-gene recurrence score assay (RS) impacts breast cancer treatment and health care costs.

Timing Matters for Pegfilgrastim Administration

Timing Matters for Pegfilgrastim Administration

The incidence of febrile neutropenia was significantly higher among patients who received pegfilgrastim prophylaxis on the same day.

Estrogen Plus Progestin Use Increases ER+ Breast Cancer Risk in African American Women

Estrogen Plus Progestin Use Increases ER+ Breast Cancer Risk in African American Women

Use of estrogen with progestin increases the risk of estrogen receptor (ER)-positive breast cancer in African American women.

CSF1R Inhibition May Ease Debilitating Adverse Event of Ovarian Cancer

Women who have ovarian cancer often develop ascites, a buildup of fluids in the abdomen. Researchers have found that ascites can be reduced with minimal side effects through inhibition of the colony-stimulating-factor-1 receptor (CSF1R).

Affordable Care Act (ACA) Impacts Stage at Diagnosis and Fertility-Sparing Treatment in Young Women With Cervical Cancer

Both the stage of cervical cancer at diagnosis and the receipt of fertility-sparing treatment among young women age 21 to 25 years, but not among women age 26 to 34 years, is associated with the Affordable Care Act Dependent Coverage Expansion provision.

New Blood Test Improves Screening for Prostate Cancer

A new test is better at detecting aggressive prostate cancer than measuring PSA levels. The new test discovers aggressive cancer earlier and reduces the number of false positive tests and unnecessary biopsies.

International Study Charts Genetic Trajectory for Melanoma

An international team of scientists has mapped out the genetic trajectories taken by melanoma as it evolves from early skin lesions to malignant skin cancer.

Risk of Several Autoimmune Diseases Increased in Childhood Cancer Survivors

Childhood cancer survivors are at heightened risk of a wide range of autoimmune diseases. Diabetes and Addison's disease make up almost half of the excess cases, according to the findings.

Protein Biomarker Assays for Diagnosing Thyroid Cancer May Show Inaccurate Readings

To test thyroid malignancy, many biomarkers are tested separately to confirm cancer. However, new research shows that the tests used to measure 2 major biomarkers in the diagnosis of thyroid cancer may be inaccurate.

New Model for Breast Cancer Risk in Hispanic Women Is the First to be Based Exclusively on Data From Hispanic Women

The first breast cancer risk-prediction model based entirely on data from Hispanic women, including whether a woman was born in or outside the United States, provides a more accurate assessment of Hispanic women's risk of developing breast cancer.

Conference Coverage

Improved Breast Cancer Outcomes Is Tied to Overall National Health Care Structures

New and better drugs to treat diseases such as advanced breast cancer will have little effect on improving patient outcomes if a country does not have good health care structures in place.

International Experts Call for Investigations Into Long-Term Management Options for Select Patients With Advanced Breast Cancer

International experts have called for a clinical trial to investigate the best ways for identifying and treating a small but important group of patients with advanced breast cancer who can survive for long periods without their disease progressing.

Patients With Advanced Breast Cancer Address an International Conference About Misleading Disease-Specific Messages

Patients with advanced breast cancer spoke out about the damaging messages some organizations issue about advanced breast cancer. They need to be identified and educated to change the way they talk about the disease.

Different Types of Ovarian Cancer Have Different Causes

The more children a woman has or whether she has undergone tubal ligation lowers her risk of different types of ovarian cancer to different levels, according to new research presented at the 2015 NCRI Cancer Conference.

Blood Test Can Guide Treatment Sequencing for Pancreatic Cancer

A widely available, inexpensive blood test can predict outcomes and guide treatment in pancreatic cancer; however, only 1 in 5 US patients with the disease have the blood test.

Sign Up for Free e-newsletters

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs